ask="100.00"
ask_size="200"
average_daily_volume="437320"
bid="N/A"
bid_size="N/A"
book_value="11.49"
change="-0.31"
change_from_200_day_moving_average="13.50"
change_from_50_day_moving_average="8.80"
change_from_52_week_high="-5.38"
change_From_52_week_low="39.45"
change_in_percent="-0.36%"
close="85.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38575000"
high="87.16"
high_52_weeks="91.35"
last_trade_date="3/10/2017"
last_trade_price="85.97"
last_trade_size="21109"
last_trade_time="4:00pm"
low="84.79"
low_52_weeks="46.52"
market_capitalization="3.59B"
moving_average_200_day="72.47"
moving_average_50_day="77.17"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="87.16"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+18.63%"
percent_change_from_50_day_moving_average="+11.40%"
percent_change_from_52_week_high="-5.88%"
percent_change_from_52_week_low="+84.80%"
previous_close="86.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.51"
price_per_sales="27068.57"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="13.64"
stock_exchange="NMS"
symbol="RARE"
volume="263409"
weeks_range_52="46.52 - 91.35"
